NABRIVA THERAPEUTICS AG's ticker is NBRVXXXX and the CUSIP is 62957M104. A total of 20 filers reported holding NABRIVA THERAPEUTICS AG in Q2 2016. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $6,300,000 | +101.7% | 525,000 | 0.0% | 0.36% | +74.2% |
| Q4 2016 | $3,124,000 | +4.0% | 525,000 | +23.2% | 0.21% | +11.2% |
| Q3 2016 | $3,003,000 | -6.0% | 426,000 | 0.0% | 0.19% | -20.7% |
| Q2 2016 | $3,195,000 | -6.2% | 426,000 | +12.1% | 0.24% | -16.8% |
| Q1 2016 | $3,405,000 | +51.7% | 380,000 | +61.7% | 0.28% | +67.6% |
| Q4 2015 | $2,244,000 | -27.2% | 235,000 | -27.6% | 0.17% | -32.0% |
| Q3 2015 | $3,082,000 | – | 324,400 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 3,151,700 | $23,638,000 | 6.46% |
| Omega Fund Management, LLC | 1,145,890 | $8,594,000 | 6.38% |
| ACUTA CAPITAL PARTNERS, LLC | 558,771 | $4,191,000 | 2.01% |
| EcoR1 Capital, LLC | 562,741 | $4,221,000 | 1.66% |
| Opaleye Management Inc. | 270,000 | $2,025,000 | 1.35% |
| Boxer Capital, LLC | 176,710 | $1,325,000 | 1.18% |
| Novo Holdings A/S | 1,054,823 | $7,911,000 | 0.83% |
| FT Options LLC | 49,555 | $372,000 | 0.32% |
| JACKSON PARK CAPITAL, LLC | 26,000 | $195,000 | 0.27% |
| Rock Springs Capital Management LP | 426,000 | $3,195,000 | 0.24% |